PharmaBioSource Realty provided real estate services to Actavis on the sale of its 103,530 SF Long Island, NY oral solid dosage development and manufacturing facility and a 110,186 SF clinical packaging facility to Ropack Pharma Solutions.

• Service: Real Estate
• Sector: Pharmaceuticals
• Sub-sector: Oral Solid Dosage / Clinical Packaging / CDMO
• Engagement Type: Sell Side

PharmaBioSource Realty provided exclusive life sciences real estate services to divest Actavis’ oral solid dosage development and manufacturing facility on Long Island, NY.  Along with the dosage form facility, Montreal-based CDMO Ropack also acquired a second Actavis facility on Long Island designed for clinical packaging. Ropack purchased the facilities to establish a presence in the U.S.

PharmaBioSource Realty’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support. 

Press Release